RT Journal Article
SR Electronic
T1 Estimated dietary intakes of vitamin A5
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2024.10.07.24315069
DO 10.1101/2024.10.07.24315069
A1 Bohn, Torsten
A1 Despotovic, Marta
A1 Vahid, Farhad
A1 Rühl, Ralph
YR 2024
UL http://medrxiv.org/content/early/2024/10/08/2024.10.07.24315069.abstract
AB A new vitamin concept, termed vitamin A5, was recently identified. Furthermore, dietary recommendations in the range of 1,1 (0,5 – 1,8) mg vitamin A5 / day were suggested by an international expert consortium. The ensuing question arises as to the current daily dietary intake amounts in the Western civilization. Addressing this answer included calculating the intake based on known amounts of vitamin A5 in frequently consumed food items of the human diet high in this vitamin as well as the known daily dietary intake amounts of those selected food components in Westernized countries. Regarding food items, amounts of vitamin A5 in the form of provitamin A5 (i.e. 9-cis-beta-carotene (9CBC)), the predominant form in the diet, were found to range from 0,1 to 39 µg 9CBC / g for individual fruits and vegetables, with highest concentrations in leafy vegetables. The average intake amounts of vitamin A5 in adults of the general population following a Western lifestyle in Europe, averaged 0,9 with a range of 0,5 (for Austria) – 1,3 (for Italy) mg 9CBC / day. Furthermore, based on our calculations, large parts, i.e. ∼ 2/3rd of the population are low, even too low (<1.1 mg/day), in daily vitamin A5 intake. In addition to the importance of nudging the population towards a regrettably non-well accepted higher intake of fruits and vegetables, an additional fortification and supplementation of vitamin A5 could be considered, similar as to other micronutrients that are low a Westernized diet.Competing Interest StatementRR is CEO and shareholder of CISCAREX UG.Funding StatementThis study did not receive any fundingAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:All mentrioned in publications listed.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesAll data produced in the present study are available upon reasonable request to the authors